Document is current
Any future updates will be listed below
-
Authors
Chowdhury, Debashish https://orcid.org/0000-0002-0293-5438
Chaudhuri, Jaydip Ray https://orcid.org/0000-0002-7560-6213
Passi, Pravar
Reddi, Rajasekar
Anand, Rajiv
Singh, Sumit
Banerjee, T. K. https://orcid.org/0000-0002-6923-7909
Sharma, Vikram
Dhore, Mayank Ravindra https://orcid.org/0000-0002-1698-7087
Charugulla, Sujeet Narayan https://orcid.org/0000-0002-3363-3272
Kotak, Bhavesh P. https://orcid.org/0000-0003-0992-1028
Singh, Sukhpreet https://orcid.org/0000-0003-0390-6521
-
Funding
Funding for this research was provided by:
Dr. Reddy’s Laboratories
- License Information
-
More Information
Article History
Received: 14 July 2025
Accepted: 4 September 2025
First Online: 16 February 2026
Declarations
:
: Nerivio ® is distributed by Dr. Reddy’s Laboratories in India. The expert committee, including Debashish Chowdhury, Jaydip Ray Chaudhuri, Pravar Passi, Rajasekar Reddi, Rajiv Anand, Sumit Singh, T K Banerjee, and Vikram Sharma, members of the scientific advisory board of Dr. Reddy’s Laboratories, declares that they have no competing interests. Mayank Ravindra Dhore, Sujeet Narayan Charugulla, Bhavesh P Kotak, and Sukhpreet Singh are employees of Dr. Reddy’s Laboratories.
: Ethical clearance for the study was obtained from the Aditya College of Engineering and Advanced Studies (ACEAS) Independent Ethics Committee, Gujarat, India, approval number EC/BQ/P-1/3/3/25, dated 03 March 2025. The study was conducted in accordance with the Declaration of Helsinki (1964) and its later amendments. All participating experts provided written informed consent before their involvement in the consensus meetings. Confidentiality of participant responses was maintained throughout the study, and any potential conflicts of interest were fully disclosed. Digital informed consent was obtained from all the experts.
